Updated Jul 16, 2026
Dukes Iain D. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Iain D. Dukes is the CEO and Chairman of Traws Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing antiviral therapies. He has also held the position of Director within the company, contributing to its mission of addressing respiratory viral diseases.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-16 | TRAW | Traws Pharma, Inc. | A — Grant or award | 36.9K | $0.00 |
Iain D. Dukes is the CEO and Chairman of Traws Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing antiviral therapies. He has also held the position of Director within the company, contributing to its mission of addressing respiratory viral diseases.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dukes Iain D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.